This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Amgen Gestione
Gestione criteri di controllo 3/4
Amgen's CEO is Bob Bradway, appointed in May 2010, has a tenure of 14.25 years. total yearly compensation is $22.64M, comprised of 7.9% salary and 92.1% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth €180.03M. The average tenure of the management team and the board of directors is 4.9 years and 7.7 years respectively.
Informazioni chiave
Bob Bradway
Amministratore delegato
US$22.6m
Compenso totale
| Percentuale dello stipendio del CEO | 7.9% |
| Mandato del CEO | 14.3yrs |
| Proprietà del CEO | 0.1% |
| Durata media del management | 4.9yrs |
| Durata media del Consiglio di amministrazione | 7.7yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$3b |
| Mar 31 2024 | n/a | n/a | US$4b |
| Dec 31 2023 | US$23m | US$2m | US$7b |
| Sep 30 2023 | n/a | n/a | US$8b |
| Jun 30 2023 | n/a | n/a | US$8b |
| Mar 31 2023 | n/a | n/a | US$8b |
| Dec 31 2022 | US$21m | US$2m | US$7b |
| Sep 30 2022 | n/a | n/a | US$7b |
| Jun 30 2022 | n/a | n/a | US$7b |
| Mar 31 2022 | n/a | n/a | US$6b |
| Dec 31 2021 | US$22m | US$2m | US$6b |
| Sep 30 2021 | n/a | n/a | US$6b |
| Jun 30 2021 | n/a | n/a | US$6b |
| Mar 31 2021 | n/a | n/a | US$7b |
| Dec 31 2020 | US$20m | US$2m | US$7b |
| Sep 30 2020 | n/a | n/a | US$7b |
| Jun 30 2020 | n/a | n/a | US$7b |
| Mar 31 2020 | n/a | n/a | US$8b |
| Dec 31 2019 | US$20m | US$2m | US$8b |
| Sep 30 2019 | n/a | n/a | US$8b |
| Jun 30 2019 | n/a | n/a | US$8b |
| Mar 31 2019 | n/a | n/a | US$8b |
| Dec 31 2018 | US$19m | US$2m | US$8b |
| Sep 30 2018 | n/a | n/a | US$2b |
| Jun 30 2018 | n/a | n/a | US$2b |
| Mar 31 2018 | n/a | n/a | US$2b |
| Dec 31 2017 | US$17m | US$2m | US$2b |
Compensazione vs Mercato: Bob's total compensation ($USD22.64M) is above average for companies of similar size in the BG market ($USD4.41M).
Compensazione vs guadagni: Bob's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Bob Bradway (61 yo)
14.3yrs
Mandato
US$22,643,650
Compensazione
Mr. Robert A. Bradway, also known as Bob, has been the Chief Executive Officer of Amgen Inc. since May 23, 2012 and has been its President since May 2010. Mr. Bradway is responsible for the Amgen's global...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman | 14.3yrs | US$22.64m | 0.12% € 180.0m | |
| Executive VP & CFO | 4.6yrs | US$7.57m | 0.0046% € 7.1m | |
| Executive Vice President of Operations | 8.1yrs | US$7.21m | 0.011% € 17.6m | |
| Executive VP & CTO | less than a year | US$7.90m | 0.0094% € 14.5m | |
| Executive Vice President of Global Commercial Operations | 5.9yrs | US$8.24m | 0.0075% € 11.5m | |
| Chief Accounting Officer & VP of Finance | less than a year | Nessun dato | 0.00056% € 860.5k | |
| Senior VP & Chief Information Officer | 5.6yrs | Nessun dato | Nessun dato | |
| Executive VP of Research & Development and Chief Scientific Officer | less than a year | Nessun dato | Nessun dato | |
| Vice President of Investor Relations | no data | Nessun dato | Nessun dato | |
| Executive VP | 9.1yrs | US$7.24m | 0.0047% € 7.2m | |
| Senior VP of Worldwide Compliance & Business Ethics and Chief Compliance Officer | 4.6yrs | Nessun dato | 0.0013% € 2.0m | |
| Senior Vice President of Global Marketing | 4.9yrs | Nessun dato | Nessun dato |
4.9yrs
Durata media
57yo
Età media
Gestione esperta: AM1's management team is considered experienced (4.9 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman | 12.8yrs | US$22.64m | 0.12% € 180.0m | |
| Lead Independent Director | 11.7yrs | US$419.92k | 0.0013% € 2.0m | |
| Co-Chair of Scientific Advisory Board | no data | US$292.01k | Nessun dato | |
| Co-Chair of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Director | 4.1yrs | US$359.92k | 0.000080% € 122.9k | |
| Independent Director | 7.5yrs | US$369.92k | 0.00023% € 353.4k | |
| Independent Director | 10.8yrs | US$379.92k | 0.0023% € 3.5m | |
| Independent Director | 7.8yrs | US$360.29k | 0.000080% € 122.9k | |
| Independent Director | 6.3yrs | US$359.92k | 0.00015% € 230.5k | |
| Independent Director | 12.3yrs | US$339.92k | 0.00051% € 783.7k | |
| Independent Director | 6.7yrs | US$359.92k | 0.0012% € 1.9m | |
| Independent Director | 3.1yrs | US$366.47k | 0.00017% € 261.2k |
7.7yrs
Durata media
68yo
Età media
Consiglio di amministrazione esperto: AM1's board of directors are considered experienced (7.7 years average tenure).